Regulatory Milestone and Analyst Optimism Fuel Momentum for Syndax Pharmaceuticals
Headquartered in Massachusetts, Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is a commercial-stage oncology company engaged in developing novel combination therapies for cancer.